Jacek Jassem
Dept. of Oncology and Radiotherapy
Medical University of Gdańsk
Gdansk
Poland
Name/email consistency: high
- Doxorubicin and paclitaxel versus fluorouracil, doxorubicin and cyclophosphamide as first-line therapy for women with advanced breast cancer: long-term analysis of the previously published trial. Jassem, J., Pienkowski, T., Pluzanska, A., Jelic, S., Gorbunova, V., Berzins, J., Nagykalnai, T., Biganzoli, L., Aloe, A., Astier, L., Munier, S. Onkologie (2009)
- Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma. Jassem, J., Ramlau, R., Santoro, A., Schuette, W., Chemaissani, A., Hong, S., Blatter, J., Adachi, S., Hanauske, A., Manegold, C. J. Clin. Oncol. (2008)
- The role of radiotherapy in lung cancer: where is the evidence?. Jassem, J. Radiother. Oncol (2007)
- P53 and K-ras mutations are frequent events in microscopically negative surgical margins from patients with nonsmall cell lung carcinoma. Jassem, J., Jassem, E., Jakóbkiewicz-Banecka, J., Rzyman, W., Badzio, A., Dziadziuszko, R., Kobierska-Gulida, G., Szymanowska, A., Skrzypski, M., Zylicz, M. Cancer (2004)
- Oral vinorelbine in combination with cisplatin: a novel active regimen in advanced non-small-cell lung cancer. Jassem, J., Kosmidis, P., Ramlau, R., Zarogoulidis, K., Novakova, L., Breton, J., Etienne, P.L., Seebacher, C., Grivaux, M., Ojala, A., Aubert, D., Lefresne, F. Ann. Oncol. (2003)
- A phase II study of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer: clinical outcomes and quality of life. Jassem, J., Krzakowski, M., Roszkowski, K., Ramlau, R., Słomiński, J.M., Szczesna, A., Krawczyk, K., Mozejko-Pastewka, B., Lis, J., Miracki, K. Lung. Cancer (2002)
- Cancer clinical trials in Central and Eastern Europe: historical review. Jassem, J., Schoket, Z., Krzakowski, M. Crit. Rev. Oncol. Hematol. (2002)
- Combined chemotherapy and radiotherapy in inoperable non-small cell lung cancer. Jassem, J. Lung. Cancer (2002)
- Chemoradiotherapy of non-small cell lung cancer. Jassem, J. Expert. Rev. Anticancer. Ther (2002)
- Doxorubicin and paclitaxel versus fluorouracil, doxorubicin, and cyclophosphamide as first-line therapy for women with metastatic breast cancer: final results of a randomized phase III multicenter trial. Jassem, J., Pieńkowski, T., Płuzańska, A., Jelic, S., Gorbunova, V., Mrsic-Krmpotic, Z., Berzins, J., Nagykalnai, T., Wigler, N., Renard, J., Munier, S., Weil, C. J. Clin. Oncol. (2001)
- Radiotherapy for non-small cell lung cancer. Jassem, J. Lung. Cancer (2001)
- Combined modality treatment with chemotherapy and radiation in locally advanced non-small cell lung cancer. Jassem, J. Lung. Cancer (2001)
- A multicenter randomized phase II study of oral vs. intravenous vinorelbine in advanced non-small-cell lung cancer patients. Jassem, J., Ramlau, R., Karnicka-Młodkowska, H., Krawczyk, K., Krzakowski, M., Zatloukal, P., Lemarié, E., Hartmann, W., Novakova, L., O'Brien, M., Depierr, A. Ann. Oncol. (2001)
- Combined chemotherapy and radiation in locally advanced non-small-cell lung cancer. Jassem, J. Lancet Oncol. (2001)
